- Report
- May 2023
- 147 Pages
Global
From €4440EUR$4,949USD£3,795GBP
- Report
- February 2023
- 118 Pages
From €3095EUR$3,450USD£2,646GBP
- Report
- February 2023
- 111 Pages
North America
From €3095EUR$3,450USD£2,646GBP
- Report
- February 2023
- 107 Pages
Africa, Middle East
From €3095EUR$3,450USD£2,646GBP
- Report
- February 2023
- 126 Pages
Europe
From €3095EUR$3,450USD£2,646GBP
- Report
- February 2023
- 135 Pages
Asia Pacific
From €3095EUR$3,450USD£2,646GBP
- Report
- December 2022
- 190 Pages
Global
From €3992EUR$4,450USD£3,413GBP
- Report
- August 2025
- 150 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- August 2026
China
From €3579EUR$3,990USD£3,060GBP
- Report
- August 2026
United Kingdom
From €3579EUR$3,990USD£3,060GBP
- Report
- July 2025
- 350 Pages
Global
From €4440EUR$4,949USD£3,795GBP
- Report
- July 2025
- 350 Pages
Global
From €4440EUR$4,949USD£3,795GBP
- Report
- December 2024
- 150 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- December 2024
- 150 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- December 2024
- 150 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- August 2025
- 23 Pages
Global
From €2646EUR$2,950USD£2,262GBP
- Report
- May 2025
- 32 Pages
Global
From €893EUR$995USD£763GBP
- Report
- March 2025
- 67 Pages
Global
From €1749EUR$1,950USD£1,495GBP
- Report
- January 2025
- 48 Pages
Global
From €2242EUR$2,499USD£1,916GBP
- Report
- January 2025
- 127 Pages
Global
From €2646EUR$2,950USD£2,262GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more